Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS
Crossref DOI link: https://doi.org/10.1038/leu.2015.312
Published Online: 2015-12-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
List, A F
Bennett, J M
Sekeres, M A
Skikne, B
Fu, T
Shammo, J M
Nimer, S D
Knight, R D
Giagounidis, A
,
Text and Data Mining valid from 2015-12-01
Version of Record valid from 2015-12-01
Article History
First Online: 9 December 2015
Free to read: This content has been made available to all.